| Literature DB >> 35873041 |
Chong Yu1, Yin Nian2, Huanhua Chen1, Shuwen Liang1, Mengyang Sun1, Yuehu Pei1,3, Haifeng Wang1,2.
Abstract
Two new pyranone derivatives phomapyrone A (2) and phomapyrone B (3), one new coumarin 11S, 13R-(+)-phomacumarin A (1), three known pyranones (4-6), together with three known amide alkaloids fuscoatramides A-C (7-9), as well as 9S, 11R-(+)-ascosalitoxin (10) were isolated from the endophytic fungus Phoma sp. YN02-P-3, which was isolated from the healthy leaf tissue of a Paulownia tree in Yunnan Province, China. Their structures were elucidated using extensive NMR spectroscopic and HRESIMS data and by comparing the information with literature data. In addition, all compounds were tested for their cytotoxicity activity against human tumor cell lines, and the results showed that new compounds 1-3 showed moderate inhibitory activity against the HL-60 cell line with IC50 values of 31.02, 34.62, and 27.90 μM, respectively.Entities:
Keywords: HL-60 inhibition; Phoma sp.; plant endophytic fungus; pyranone derivatives; secondary metabolites
Year: 2022 PMID: 35873041 PMCID: PMC9300907 DOI: 10.3389/fchem.2022.950726
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
FIGURE 1Structure of the identified compounds 1–10.
1H NMR and 13C NMR spectral data in DMSO-d 6 for compound 1.x
| Position |
|
|
|---|---|---|
| 2 | 160.2 | |
| 3 | 6.27 (1H, d, | 111.1 |
| 4 | 8.34 (1H, d, | 141.1 |
| 5 | 136.9 | |
| 6 | 6.61 (1H, s) | 110.9 |
| 7 | 159.0 | |
| 8 | 109.8 | |
| 9 | 154.3 | |
| 10 | 109.5 | |
| 11 | 4.58 (1H, q, | 44.6 |
| 12 | 2.35 (1H, m) | 212.6 |
| 13 | 1.45 (1H, m) | 45.7 |
| 14 | 1.15 (1H, m) | 24.9 |
| 15 | 0.53 (3H, t, | 11.4 |
| 16 | 2.12 (3H, s) | 7.8 |
| 17 | 1.25 (3H, d, | 18.1 |
| 18 | 0.99 (3H, d, | 17.0 |
| 7-OH | 10.49(1H, s) |
1H NMR and 13C NMR spectral data in DMSO-d 6 for compounds 2–3.
| Position | Compound 2 | Compound 3 | ||
|---|---|---|---|---|
|
|
|
|
| |
| 2 | 163.9 | 163.8 | ||
| 3 | 109.8 | 109.9 | ||
| 4 | 168.9 | 168.9 | ||
| 5 | 113.9 | 114.1 | ||
| 6 | 162.0 | 161.5 | ||
| 7 | 25.7 | 2.84 (2H, t, 7.4) | 25.6 | 2.88 (2H, t, 7.4) |
| 8 | 31.2 | 2.55 (2H, t, 7.4) | 31.1 | 2.63 (2H, t, 7.4) |
| 9 | 173.1 | 171.6 | ||
| 10 | 53.3 | 4.32 (2H, s) | ||
| 11 | 53.2 | 4.26 (2H, s) | 63.8 | 4.02 (2H, t, 6.5) |
| 12 | 62.0 | 4.06 (3H, s) | 30.1 | 1.53 (2H, m) |
| 13 | 18.6 | 1.31 (2H, m) | ||
| 14 | 13.5 | 0.88 (3H, t, 7.3) | ||
| 15 | 53.2 | 4.32 (2H, d, 4.0) | ||
| 16 | 53.3 | 4.25 (2H, d, 4.0) | ||
| 17 | 62.0 | 4.06 (3H, s) | ||
| 10-OH | 4.96 (1H, s) | |||
| 15,16-OH | 4.96 (2H, m) | |||
FIGURE 2Key HMBC (blue) and NOESY (red) correlations of 1–3.
FIGURE 3Global minimum energy structures of the four possible diastereoisomers of compound 1.
In vitro cytostatic activities of compounds (1–10).
| No. | HL-60 (IC50 | PC-3 (IC50 | HT-29 (IC50 |
|---|---|---|---|
| 1 | 31.02 | >50 | >50 |
| 2 | 34.62 | >50 | >50 |
| 3 | 27.90 | >50 | >50 |
| 4 | >50 | >50 | >50 |
| 5 | >50 | >50 | >50 |
| 6 | >50 | >50 | >50 |
| 7 | >50 | >50 | >50 |
| 8 | >50 | >50 | >50 |
| 9 | 41.07 | >50 | >50 |
| 10 | >50 | >50 | >50 |
| 5-Fluorouridine | 6.38 | 7.77 | 5.82 |